Spark Investment Management LLC Purchases 26,400 Shares of Invuity Inc (IVTY)
Spark Investment Management LLC raised its position in shares of Invuity Inc (NASDAQ:IVTY) by 138.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 45,500 shares of the medical instruments supplier’s stock after buying an additional 26,400 shares during the quarter. Spark Investment Management LLC owned about 0.19% of Invuity worth $177,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Cannell Capital LLC purchased a new position in shares of Invuity in the 1st quarter worth about $4,235,000. Needham Investment Management LLC raised its position in shares of Invuity by 76.5% in the 1st quarter. Needham Investment Management LLC now owns 692,200 shares of the medical instruments supplier’s stock worth $2,664,000 after purchasing an additional 300,000 shares during the last quarter. Millennium Management LLC raised its position in shares of Invuity by 22.9% in the 1st quarter. Millennium Management LLC now owns 513,666 shares of the medical instruments supplier’s stock worth $1,978,000 after purchasing an additional 95,550 shares during the last quarter. Perkins Capital Management Inc. raised its position in shares of Invuity by 42.8% in the 2nd quarter. Perkins Capital Management Inc. now owns 311,450 shares of the medical instruments supplier’s stock worth $1,215,000 after purchasing an additional 93,400 shares during the last quarter. Finally, Neuberger Berman Group LLC purchased a new position in shares of Invuity in the 1st quarter worth about $485,000. 59.95% of the stock is owned by institutional investors and hedge funds.
In other Invuity news, Director Eric W. Roberts bought 12,500 shares of the firm’s stock in a transaction on Friday, June 8th. The stock was acquired at an average price of $3.73 per share, with a total value of $46,625.00. Following the transaction, the director now owns 163,795 shares in the company, valued at $610,955.35. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 8.41% of the stock is currently owned by insiders.
Invuity (NASDAQ:IVTY) last issued its earnings results on Thursday, August 2nd. The medical instruments supplier reported ($0.37) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.47) by $0.10. Invuity had a negative return on equity of 837.22% and a negative net margin of 89.29%. The business had revenue of $10.50 million during the quarter, compared to analyst estimates of $10.73 million. sell-side analysts forecast that Invuity Inc will post -1.41 earnings per share for the current year.
Several equities analysts have recently issued reports on IVTY shares. Zacks Investment Research raised Invuity from a “hold” rating to a “buy” rating and set a $3.50 price target for the company in a research report on Thursday, May 3rd. Stifel Nicolaus lowered their price target on Invuity from $6.00 to $5.00 and set a “buy” rating for the company in a research report on Friday, May 4th. Finally, ValuEngine raised Invuity from a “sell” rating to a “hold” rating in a research report on Saturday, June 2nd. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $6.81.
Invuity, Inc, a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities.
Recommended Story: Do You Need a Fiduciary?
Want to see what other hedge funds are holding IVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invuity Inc (NASDAQ:IVTY).
Receive News & Ratings for Invuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity and related companies with MarketBeat.com's FREE daily email newsletter.